Alexandria Venture Investments focuses on disruptive life science, agrifood tech, and technology companies developing transformative platforms to improve human health. The firm invests across various stages, from seed to late-stage rounds, with a particular emphasis on Series A and B investments. Their strategic venture capital platform provides deep insights into key macro life science industry trends.

Notable portfolio companies include Moderna, Insitro, and Kallyope. Alexandria Venture Investments offers valuable industry connections and expertise to its portfolio companies, leveraging its position as a leading real estate investment trust specializing in life science, agtech, and technology campuses. The firm's investments span a wide range of therapeutic areas and technologies, reflecting its commitment to advancing innovative solutions in healthcare and biotechnology.